Abnormal T cell function is a feature of a spectrum of inherited and acquired diseases. We have detected a frequent restriction fragment length polymorphism in the human T cell antigen receptor ,8-chain locus that may aid in the analysis of these disorders. A study of a panel of 18 normal individuals, testing for the presence of the polymorphism, showed it to account for 36% of the alleles in that group. In view of the fact that the T cell receptor (-chain locus has been mapped to chromosome 7, and that the disease ataxia telangiectasia (AT) is associated both with abnormal T cell function and with chromosomal abnormalities of the same region of chromosome 7, we investigated the possibility that the polymorphism could demonstrate linkage of the T cell receptor locus to the gene for that disease. We demonstrated that the mutation causing AT did not lie within the (3-chain locus itself, and that there was preliminary evidence that the two loci were not closely linked. This polymorphism may provide a useful tool for the study of other genetic disorders associated with abnormalities of T cell function, as well as disorders associated with inherited or acquired abnormalities of chromosome 7.
Introduction
The complex immunologic repertoire of the T lymphocyte is still poorly understood. T cell dysfunction is part ofa wide range of abnormalities, from congenital immunodeficiency syndromes to acquired autoimmune diseases and infectious and neoplastic immune suppression. The recent cloning of the (-chain of the receptor on the surface of the T lymphocyte (1, 2) offers new opportunities to understand the early steps in antigen recognition by that cell and may offer insights into the mechanism of T cell dysfunction in some of these disorders. In this study, we have defined a restriction fragment length polymorphism (RFLP)' of the T cell receptor (3- (4, 5) , thalassemia (6) , and Huntington's disease (7) . We have detected an RFLP in the T cell (3-chain locus with which similar analyses may be performed. We have documented its frequent occurrence in a group of normal individuals. We then evaluated the possible relation of the RFLP, and by inference, the T cell receptor (3-chain locus, to the disease ataxia telangiectasia (AT).
AT is an autosomal recessive disorder associated with multiple neurologic and immunologic defects. Patients become symptomatic at an early age, with progressive cerebellar ataxia, oculocutaneous telangiectasia, and immunodeficiency. The disease is associated with increased chromosomal breakage and rearrangement and a predisposition to the development of malignancy. It is almost uniformly fatal, with death usually due to chronic pulmonary infections or malignancy (8) .
AT is of interest when studying the 3-chain locus for two reasons. Firstly, it is associated with T cell dysfunction. Secondly, it is associated with a high frequency of chromosome 7 rearrangements (9, 10). The T cell :3-chain locus has been localized to chromosome 7 by somatic cell hybrids (11, 12) and chromosomal in situ hybridization (13) . Regional assignment has been controversial, but recent in situ hybridization indicates that the genes are located at 7q32 with a secondary region of related sequences seen at 7p1 5-21 (14) . These are precisely the areas on chromosome 7 at which the rearrangements in AT are known to occur (9, 10) . Studies of the chromosomal translocations in Burkitt's lymphoma, in which the c-myc oncogene is brought into association with the immunoglobulin loci (15) , have provided a model for relating cytogenetic abnormalities to regions of the genome that may have pathogenetic significance in the development of disease. Consistent with this model, the observations in patients with AT raised the intriguing possibility that the mutation giving rise to AT might involve a gene within, or in close proximity to, the T cell receptor (-chain locus.
Methods
Lymphoblastoid cell lines from patients with AT and their families were obtained from the Institute for Medical Research (Camden, NJ). High molecular weight DNA was prepared from peripheral blood cells from normal individuals and from the lymphoblastoid cell lines from patients with AT and their families (16) . DNA was digested with the restriction enzyme Bgl II, size fractionated by agarose gel electrophoresis, and transferred onto nitrocellulose paper by the method of Southern (17) . Filters were hybridized overnight to a nick-translated, 32P-labeled probe from the second constant region of the T cell #-chain locus (Fig. I A) , and washed at 530C in 0.1% sodium dodecyl sulfate and 0.015 M NaCl and 0.0015 M Na citrate before autoradiography.
Results
The organization of the (3-chain locus is diagramed in Fig. 1 A.
The two constant region genes (CflI and C,32) are physically linked and lie -12 kilobases (kb) from one another (18, 19) . The probe used to analyze genomic DNA was a 1.0-kb Bgl IIBgi II fragment derived from C(32 as demonstrated in the figure. The two constant region genes are highly homologous in the coding region; therefore, this fragment hybridizes equally to both genes. After the DNA was digested with Bgl II and filters were hybridized to this probe, there were two restriction fragments predicted. The first resulted from hybridization to C(31 on a restriction fragment of 10 kb; the second resulted from hybridization to C32 on a fragment of 1 kb corresponding to the length of the probe itself. The blot in Fig. 1 B demonstrates that, in some cases, three bands were seen. The third band is 11.5 kb in length and may be best explained by a polymorphism leading to the absence of the Bgl II site lying 1.5 kb 5' of Cf32. An R1-Bgl II probe lying just 5' to the first probe ( Fig. 1 Figure 2 . Analysis of the frequency of the Bgl II polymorphism in normal individuals. Southern blot analysis was performed using the previously described probe to investigate the occurrence of the RFLP in a panel of 18 normal individuals. Analysis reveals 6 individuals homozygous for the 10-kb allele, I individual homozygous for the 11.5-kb allele, and 11 individuals heterozygous for the two alleles.
23 of 36 (64%) alleles lay on the shorter restriction fragment and 13 of 36 (36%) lay on the longer fragment.
In view of the fact that the :-chain locus has been mapped to chromosome 7, and that AT patients have been noted to have a high frequency of abnormalities in the same region of chromosome 7, we attempted to show linkage of the gene for AT to this locus. DNAs from patients with AT and their families were screened to find an informative distribution of the polymorphism. One family was found in which two parents heterozygous for the RFLP had a homozygous affected child. Analysis of that family revealed that AT did not segregate with the (-chain locus, as the patient had an unaffected sibling who was homozygous for the same allele (Fig. 3 ).
Discussion
We have described an RFLP in the T cell (-chain locus and documented its frequent occurrence in a group of normal individuals. We have used this polymorphism to analyze the inheritance pattern of the (-chain locus in an individual with AT and his family. By this means, we have shown that the inheritance of a particular (-chain locus genotype does not determine the inheritance of AT.
RFLPs can be related to diseases caused by single gene defects in at least three ways. The mutation causing the disease may itself give rise to an altered restriction enzyme site. In such a case, the presence of the RFLP may be equated with presence of the mutant allele; it is seen only in carriers and affected individuals, and not in the general population. Alternatively, the RFLPs may arise within the locus of the gene of interest independently from the mutation that causes the disease. The RFLPs reflect common mutations associated with, but not responsible for, the less frequent mutations that alter gene expression and cause disease. Thus, the RFLP will not directly identify affected individuals in the general population but will be diagnostic in a family known to carry a mutant gene in association with a given RFLP. Finally, the RFLP may not lie within the locus of the gene of interest at all, but may lie close enough to the gene so that the two loci rarely, if ever, become separated by recombination. The diagnostic value of the RFLP then depends on statistical analysis of the proximity of the two genes.
In our analysis of a single family, we identified both an affected and an unaffected child who inherited the same T cell 13-chain locus alleles from their parents. This demonstrates that, at least in this family, the gene for AT does not lie within the T cell 3-chain locus itself. We have not absolutely excluded the possibility that the two loci are linked by the third way described above. One family is insufficient to make this determination. The two genes may be linked, with recombination having occurred in this family. The fact that in one of four offspring in a single pedigree the genes for AT and the two 13-chain alleles segregate independently merely suggests that the two loci are probably not tightly linked. AT is also an extremely heterogeneous disease, and it is possible that in other pedigrees with a different genotypic abnormality the gene may be shown to be related to the 13-chain locus.
Although we have not shown linkage of the RFLP to the locus for the disease AT, the polymorphism we have described should prove useful in analyzing other phenomena related to T cell function and dysfunction. The T cell receptor 1-chain locus undergoes rearrangement in a manner analogous to the immunoglobulin heavy chain locus (20) . This and the evidence that chromosome 7 rearrangements occasionally occur in the same region in short-term lymphocyte cultures of normal individuals (21) suggest that the locus lies in a region of the genome that undergoes active recombination. Again using the immunoglobulin locus as a model, this functional recombinant activity may also give rise to aberrant and dysfunctional rearrangements. It seems likely that the polymorphism will prove useful in the analysis of other disorders associated with inherited or acquired abnormalities of this region of the genome.
